TrialBMC neurology2023

The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy.

Aaron Yarlas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.